REFERENCES
1. Ellis CA, Petrovski S, Berkovic SF. Epilepsy genetics: clinical impacts and biological insights. Lancet Neurol 2020;19:93-100.
2. Symonds JD, Zuberi SM, Stewart K, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain 2019;142:2303-18.
3. Symonds JD, McTague A. Epilepsy and developmental disorders: next generation sequencing in the clinic. Eur J Paediatr Neurol 2020;24:15-23.
4. Hebbar M, Mefford HC. Recent advances in epilepsy genomics and genetic testing. F1000Res 2020;9:185.
5. Kalser J, Cross JH. The epileptic encephalopathy jungle - from Dr West to the concepts of aetiology-related and developmental encephalopathies. Curr Opin Neurol 2018;31:216-22.
6. Johnson MR, Shorvon SD. Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. Epilepsy Behav 2011;22:421-7.
7. Shankar R, Perera B, Thomas RH. Epilepsy, an orphan disorder within the neurodevelopmental family. J Neurol Neurosurg Psychiatry 2020;91:1245-7.
8. Striano P, Minassian BA. From genetic testing to precision medicine in epilepsy. Neurotherapeutics 2020;17:609-15.
9. Heinzen EL. Somatic variants in epilepsy - advancing gene discovery and disease mechanisms. Curr Opin Genet Dev 2020;65:1-7.
10. Jesus-Ribeiro J, Pires LM, Melo JD, et al. Genomic and epigenetic advances in focal cortical dysplasia types I and II: a scoping review. Front Neurosci 2020;14:580357.
11. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85.
12. Korff CM, Brunklaus A, Zuberi SM. Epileptic activity is a surrogate for an underlying etiology and stopping the activity has a limited impact on developmental outcome. Epilepsia 2015;56:1477-81.
13. Specchio N, Curatolo P. Developmental and epileptic encephalopathies: what we do and do not know. Brain 2021;144:32-43.
14. Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: beyond SCN1A. Epilepsia 2017;58:1807-16.
15. Aledo-Serrano A, Mingorance A. [Analysis of the family impact and needs of Dravet's syndrome in Spain]. Rev Neurol 2020;70:75-83.
16. Brunklaus A, Zuberi SM. Dravet syndrome - from epileptic encephalopathy to channelopathy. Epilepsia 2014;55:979-84.
17. Riva A, Coppola A, Balagura G, et al. Temporal-parietal-occipital epilepsy in GEFS+ associated with SCN1A mutation. Epileptic Disord 2021;23:397-401.
18. Scheffer IE, Nabbout R. SCN1A-related phenotypes: epilepsy and beyond. Epilepsia 2019;60 Suppl 3:S17-24.
19. Guerrini R, Balestrini S, Wirrell EC, Walker MC. Monogenic epilepsies: disease mechanisms, clinical phenotypes, and targeted therapies. Neurology 2021;10.1212/WNL.0000000000012744.
20. Scala M, Efthymiou S, Sultan T, et al. Homozygous SCN1B variants causing early infantile epileptic encephalopathy 52 affect voltage-gated sodium channel function. Epilepsia 2021;62:e82-7.
21. Song M, Liu J, Yang Y, Lv L, Li W, Luo XJ. Genome-wide meta-analysis identifies two novel risk loci for epilepsy. Front Neurosci 2021;15:722592.
22. Symonds JD, Zuberi SM. Genetics update: monogenetics, polygene disorders and the quest for modifying genes. Neuropharmacology 2018;132:3-19.
23. Perucca P, Bahlo M, Berkovic SF. The genetics of epilepsy. Annu Rev Genomics Hum Genet 2020;21:205-30.
24. Takata A, Nakashima M, Saitsu H, et al. Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy. Nat Commun 2019;10:2506.
25. Greenberg DA, Stewart WC. How should we be searching for genes for common epilepsy? Epilepsia 2012;53 Suppl 4:72-80.
26. Leu C, Stevelink R, Smith AW, et al. Epi25 Consortium. Polygenic burden in focal and generalized epilepsies. Brain 2019;142:3473-81.
27. Liu X, Shen Q, Zheng G, et al. Gene and phenotype expansion of unexplained early infantile epileptic encephalopathy. Front Neurol 2021;12:633637.
28. Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017;542:433-8.
29. Allen AS, Berkovic SF, Cossette P, et al. Epi4K Consortium, Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 2013;501:217-21.
30. Milh M, Villeneuve N, Chouchane M, et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations. Epilepsia 2011;52:1828-34.
31. Wild B, Nelson S. STXBP1-related developmental and epileptic encephalopathy. Pediatr Neurol Briefs 2019;33:6.
32. Abramov D, Guiberson NGL, Burré J. STXBP1 encephalopathies: clinical spectrum, disease mechanisms, and therapeutic strategies. J Neurochem 2021;157:165-78.
33. Suri M, Evers JMG, Laskowski RA, et al. DDD Study. Protein structure and phenotypic analysis of pathogenic and population missense variants in STXBP1. Mol Genet Genomic Med 2017;5:495-507.
34. Liu X, Sun X, Sun C, et al. Prevalence of epilepsy in autism spectrum disorders: a systematic review and meta-analysis. Autism 2021:13623613211045029.
35. Swietlik EM, Prapa M, Martin JM, et al. 'There and back again'-forward genetics and reverse phenotyping in pulmonary arterial hypertension. Genes (Basel) 2020;11:1408.
36. Samanta D. PCDH19-related epilepsy syndrome: a comprehensive clinical review. Pediatr Neurol 2020;105:3-9.
37. Aledo-Serrano Á, Del Ser T, Gil-Nagel A. Antiseizure medication withdrawal in seizure-free patients with PCDH19-related epilepsy: a multinational cohort survey. Seizure 2020;80:259-61.
38. Sadleir LG, Kolc KL, King C, et al. Levetiracetam efficacy in PCDH19 girls clustering epilepsy. Eur J Paediatr Neurol 2020;24:142-7.
39. Chakravorty S, Hegde M. Gene and variant annotation for mendelian disorders in the era of advanced sequencing technologies. Annu Rev Genomics Hum Genet 2017;18:229-56.
40. Sayers EW, Beck J, Bolton EE, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res 2021;49:D10-7.
41. Byrne S, Enright N, Delanty N. Precision therapy in the genetic epilepsies of childhood. Dev Med Child Neurol 2021; doi: 10.1111/dmcn.14929.
42. Sobreira NLM, Arachchi H, Buske OJ, et al. Matchmaker Exchange Consortium. Matchmaker exchange. Curr Protoc Hum Genet 2017;95:9.31.1-9.31.15.
43. Wohler E, Martin R, Griffith S, et al. PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data. Orphanet J Rare Dis 2021;16:365.
44. Azzariti DR, Hamosh A. Genomic data sharing for novel mendelian disease gene discovery: the matchmaker exchange. Annu Rev Genomics Hum Genet 2020;21:305-26.
45. Møller RS, Hammer TB, Rubboli G, Lemke JR, Johannesen KM. From next-generation sequencing to targeted treatment of non-acquired epilepsies. Expert Rev Mol Diagn 2019;19:217-28.
46. Aledo-Serrano Á, Gómez-Iglesias P, Toledano R, et al. Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency disorder: findings from a multicenter cohort. Epilepsy Behav 2021;118:107946.
47. Wu AC, McMahon P, Lu C. Ending the diagnostic odyssey - is whole-genome sequencing the answer? JAMA Pediatr 2020;174:821-2.
48. Espinosa-Jovel C, Toledano R, Aledo-Serrano Á, García-Morales I, Gil-Nagel A. Epidemiological profile of epilepsy in low income populations. Seizure 2018;56:67-72.
49. Raspa M, Moultrie R, Toth D, Haque SN. Barriers and facilitators to genetic service delivery models: scoping review. Interact J Med Res 2021;10:e23523.
50. Aledo-Serrano A, García-Morales I, Toledano R, et al. Diagnostic gap in genetic epilepsies: a matter of age. Epilepsy Behav 2020;111:107266.
51. Richards S, Aziz N, Bale S, et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24.
52. Frebourg T. The challenge for the next generation of medical geneticists. Hum Mutat 2014;35:909-11.
53. Achkar CM, Harrer M, Smith L, et al; GABRB2 Working Group. Characterization of the GABRB2-associated neurodevelopmental disorders. Ann Neurol 2021;89:573-86.
54. Bamshad MJ, Nickerson DA, Chong JX. Mendelian gene discovery: fast and furious with no end in sight. Am J Hum Genet 2019;105:448-55.
55. Strande NT, Riggs ER, Buchanan AH, et al. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am J Hum Genet 2017;100:895-906.
56. Carvill GL, Helbig KL, Myers CT, et al. Damaging de novo missense variants in EEF1A2 lead to a developmental and degenerative epileptic-dyskinetic encephalopathy. Hum Mutat 2020;41:1263-79.
57. Harrison SM, Biesecker LG, Rehm HL. Overview of specifications to the ACMG/AMP variant interpretation guidelines. Curr Protoc Hum Genet 2019;103:e93.
58. Moyses-Oliveira M, Yadav R, Erdin S, Talkowski ME. New gene discoveries highlight functional convergence in autism and related neurodevelopmental disorders. Curr Opin Genet Dev 2020;65:195-206.
59. Gago-Veiga AB, Toledano R, García-Morales I, Pérez-Jiménez MA, Bernar J, Gil-Nagel A. Specificity of electroclinical features in the diagnosis of ring chromosome 20. Epilepsy Behav 2018;80:215-20.
60. Peron A, Au KS, Northrup H. Genetics, genomics, and genotype-phenotype correlations of TSC: insights for clinical practice. Am J Med Genet C Semin Med Genet 2018;178:281-90.
61. Scala M, Bianchi A, Bisulli F, et al. Advances in genetic testing and optimization of clinical management in children and adults with epilepsy. Expert Rev Neurother 2020;20:251-69.
62. Jiang T, Gao J, Jiang L, et al. Application of trio-whole exome sequencing in genetic diagnosis and therapy in chinese children with epilepsy. Front Mol Neurosci 2021;14:699574.
63. Bayat A, Bayat M, Rubboli G, Møller RS. Epilepsy syndromes in the first year of life and usefulness of genetic testing for precision therapy. Genes (Basel) 2021;12:1051.
64. Amadori E, Scala M, Cereda GS, et al. Targeted re-sequencing for early diagnosis of genetic causes of childhood epilepsy: the Italian experience from the 'beyond epilepsy' project. Ital J Pediatr 2020;46:92.
65. Leblond CS, Le TL, Malesys S, et al. Operative list of genes associated with autism and neurodevelopmental disorders based on database review. Mol Cell Neurosci 2021;113:103623.
66. Zacher P, Mayer T, Brandhoff F, et al. The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals. Genet Med 2021;23:1492-7.
67. Zou D, Wang L, Liao J, et al. Genome sequencing of 320 Chinese children with epilepsy: a clinical and molecular study. Brain 2021:awab233.
68. Myers KA, Johnstone DL, Dyment DA. Epilepsy genetics: current knowledge, applications, and future directions. Clin Genet 2019;95:95-111.
69. Eldomery MK, Coban-Akdemir Z, Harel T, et al. Lessons learned from additional research analyses of unsolved clinical exome cases. Genome Med 2017;9:26.
70. Ghosh SG, Scala M, Beetz C, et al. Undiagnosed Diseases Network. A relatively common homozygous TRAPPC4 splicing variant is associated with an early-infantile neurodegenerative syndrome. Eur J Hum Genet 2021;29:271-9.
71. Basel-Salmon L, Orenstein N, Markus-Bustani K, et al. Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested. Genet Med 2019;21:1443-51.
72. Zahrani H, Siriwardena K, Young D, Lehman A, Horvath GA, Goez H. Genomics in Cerebral Palsy phenotype across the lifespan: comparison of diagnostic yield between children and adult population. Mol Genet Metab ;2021:S1096-7192(21)00758.
73. Bozkurt T, Alanay Y, Isik U, Sezerman U. Re-analysis of whole-exome sequencing data reveals a novel splicing variant in the SLC2A1 in a patient with GLUT1 Deficiency Syndrome 1 accompanied by hemangioma: a case report. BMC Med Genomics 2021;14:197.
74. Dunn P, Albury CL, Maksemous N, et al. Next generation sequencing methods for diagnosis of epilepsy syndromes. Front Genet 2018;9:20.
75. Woerner AC, Gallagher RC, Vockley J, Adhikari AN. The use of whole genome and exome sequencing for newborn screening: challenges and opportunities for population health. Front Pediatr 2021;9:663752.
76. Vamathevan J, Birney E. A review of recent advances in translational bioinformatics: bridges from biology to medicine. Yearb Med Inform 2017;26:178-87.
77. Kobow K, Baulac S, von Deimling A, Lee JH. Molecular diagnostics in drug-resistant focal epilepsy define new disease entities. Brain Pathol 2021;31:e12963.
